VIS
BPMC

Vega Investment Solutions’s Blueprint Medicines BPMC Stock Holding History

Vega Investment Solutions’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$39.7K Sell
310
-287
-48% -$29.8K 0.01% 122
2025
Q1 		$52.8K Buy
+597
New +$58.2K 0.01% 157

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vega Investment Solutions's BPMC Position: Q2 2025 in Review

Vega Investment Solutions reduced its Blueprint Medicines (BPMC) stake by 48% in Q2 2025, selling an estimated $29.8K and leaving 310 shares worth $39.7K. The position accounts for 0.01% of the portfolio, ranked #122.

Vega Investment Solutions first reported a position in BPMC in Q1 2025 and has held it in 2 quarters since. The position peaked at $52.8K in Q1 2025. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Vega Investment Solutions held 310 shares of Blueprint Medicines worth $39.7K as of Q2 2025.
  • Vega Investment Solutions sold 287 Blueprint Medicines shares in Q2 2025, an estimated $29.8K.
  • Blueprint Medicines made up 0.01% of Vega Investment Solutions's portfolio in Q2 2025, its #122 holding.
  • Vega Investment Solutions first reported a position in Blueprint Medicines in Q1 2025 and has held it in 2 quarters since.
  • Vega Investment Solutions's Blueprint Medicines position peaked at $52.8K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Vega Investment Solutions's 13F filing for Q2 2025, filed 13 Aug 2025.